CohBar to Present at the Oppenheimer Fall Healthcare, Life Sciences, & MedTech Summit

Sep 10, 2020

CohBar to Present at the H.C. Wainwright Annual Global Investment Conference

Sep 3, 2020

CohBar Announces Closing of Public Offering of Common Stock and Warrants

Aug 28, 2020

CohBar Announces Pricing of $15.0 Million Public Offering of Common Stock and Warrants

Aug 26, 2020

CohBar Announces Proposed Public Offering of Common Stock and Warrants

Aug 25, 2020

CohBar Announces First Subjects Dosed in its Phase 1b Clinical Trial for CB4211 Under Development for NASH and Obesity

Aug 24, 2020

CohBar Reports Second Quarter 2020 Financial Results and Provides Business Update

Aug 13, 2020

CohBar Presents New Antifibrotic Data at the American Thoracic Society’s Virtual 2020 Conference

Aug 5, 2020

CohBar to Announce 2020 Second Quarter Financial Results and Provide Business Update on August 13, 2020

Jul 30, 2020

CohBar Resumes CB4211 Phase 1b Clinical Trial

Jul 7, 2020